Quotient Limited Provides First Quarter Fiscal 2023 Results

MosaiQ™ Solution Commercial Execution: Extended IH Launch: $1.4 million MosaiQ bookings completed with $0.4 million in revenue in the first...

Related Keywords

Jersey , Netherlands , Singapore , Florida , United States , Boston , Massachusetts , Delft , Zuid Holland , Orlando , Eysins , Switzerland General , Switzerland , Spain , Castillay Le , Hemoterapiay Hemodonaci , Steven Zuiderwijk , Distribution Network , Extractable Nuclear Antibody , University Of Delft , Strategic Business Development , Nuclear Antibody , Strategy Business Development , Quotient Limited , Philips , Master Of Business Administration , Leadership Team , Scientific Medical Affairs , Extractable Nuclear Antibodies , Boston Consulting Group , Extended Immunohematology , Extended Serological Disease Screening , Connective Tissue Autoimmune Disease , Medical Affairs , Transfusion Interregionale , Centro De Hemoterapia , Advisory Board , Scientific Advisory Board , Autoimmune Testing , Mosaiq Immunohematology Donor Extended Microarray , Chief Strategy , Business Development Officer , Channel Islands , Chief Executive Officer , Infynity Biomarkers , Mosaiq Serology Disease Screening , Connective Tissue Diseases , Anti Nuclear Antibody , Mosaiq Innovator , Chief Strategic Business Development Officer , Precision Diagnosis , Middle East , Mechanical Engineering , Business Administration , First Quarter Financial Results , Nasdaq Qtnt ,